PNEUMOVAX 23 sol inj ser pré 0.5 ml

7680656750035 CH-65675 J07AL01 08.08.

Reimbursement limitations:

0808 NEU

La prise en charge des coûts des vaccins au titre de mesure préventive dans le …

PNEUMOVAX 23 sol inj ser pré 0.5 ml
PNEUMOVAX 23 sol inj ser pré 0.5 ml
PNEUMOVAX 23 sol inj ser pré 0.5 ml
1 / 3
google

Details

Product number
6567501
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6B 25 µg, polysaccharida streptococci pneumoniae typus 7F 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9N 25 µg, polysaccharida streptococci pneumoniae typus 9V 25 µg, polysaccharida streptococci pneumoniae typus 10A 25 µg, polysaccharida streptococci pneumoniae typus 11A 25 µg, polysaccharida streptococci pneumoniae typus 12F 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15B 25 µg, polysaccharida streptococci pneumoniae typus 17F 25 µg, polysaccharida streptococci pneumoniae typus 20 25 µg, polysaccharida streptococci pneumoniae typus 22F 25 µg, polysaccharida streptococci pneumoniae typus 23F 25 µg, polysaccharida streptococci pneumoniae typus 33F 25 µg, natrii chloridum corresp. natrium 1.8 mg, phenolum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Pneumovax-23, Injektionslösung in einer Fertigspritze
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
20/01/2023
Professional SmPC
Français
20/01/2023
Professional SmPC
Italien
20/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.8 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 37.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2021

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
65675
Drug name
Pneumovax-23, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
J07AL01
Authorization status
Z
Dispensation category
B
First authorization
26/02/2016
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen, insbesondere Pneumonien, ab dem vollendeten 2. Lebensjahr

Packaging details

Description (FR)
PNEUMOVAX 23 sol inj 1 pce
Description (DE)
PNEUMOVAX 23 Inj Lös 1 Stk
Market launch
26/02/2016
Narcotic (BTM)
No

Other packaging sizes

PNEUMOVAX 23 sol inj 10 pce
10 FESP
View